BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 13, 2007
View Archived Issues
Onyx Skyrockets On Phase III Nexavar Data In Liver Cancer
Shares of Onyx Pharmaceuticals Inc. soared more than 95 percent on news that its kidney cancer drug, Nexavar, yielded positive survival data in a Phase III trial in liver cancer patients. (BioWorld Today)
Read More
Panel Deliberates Ideas To Fund Global Health Products
Read More
CTI Spins Out Aequus To Develop Follow-On Biologics
Read More
Biodel Files For IPO To Fund Peptide Hormone Formulations
Read More
Other News To Note
Read More
Clinic Roundup
Read More